All News about Replimune Group Inc![]()
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Analyst Ratings for Replimune Group
December 07, 2022
Via Benzinga
![]() ![]()
Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform
December 12, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
Via Benzinga
![]() Via Benzinga
![]()
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 07, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Replimune Group Inc (NQ: REPL )All News about Replimune Group Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|